baber/WOPTO huggingface dataset:
Patent FI-932709-A0 (FI)
Inventor: LOESEL WALTER
IPC: A61P7/02
Filed: 1993-06-14
Abstract: 3,4-Dihydro-6,7-dimethoxy -1-(alpha-(bis(2-(2,3,4- trimethoxyphenyl)ethyl) -carbamoyl)benzyl)isoquinoline of formula (Ia) and its salts are new. Fused-ring dihydropyridine derivs. of formula (II) and their tautomers, salts and complexes are used as cerebroprotective agents, agents for treating chronic inflammatory disorders, and anticoagulants: X = OR1, NHR2 or NR3R4; R1 = H, 1-4C alkyl or 2-4C alkoxyalkyl; R2 = (a) e.g. H, 3-6C alkenyl, or (b) e.g. 1-6C alkyl opt. substd. by e.g. halogen, CN, OH, SH, 1-4C alkoxy; R3 and R4 = 1-4C alkyl opt. substd. by Ar2 or NR3R4 is a satd. or partially satd. opt. substd. 5- or 6-membered ring, opt. contg. up to two further heteroatoms (N, O and/or S): Ar1, Ar2 and R5 = phenyl opt. substd. by e.g. halogen, 1-4C alkoxy; Het = indolyl or 5- or 6-membered opt. substd. heterocyclyl contg. 1-3 heteroatoms (N, O and/or S); A = a gp. of formula A1-A4;: R5 is e.g. H, 1-4C alkyl; R6 and R7 is H, OH or R6+R7 = O(CH2)nO; R9 = H or 1-4C alkyl; R10 = H or 2-phenyl-2-ethoxycarbonylacetyl. Cpds. (I), other than (Ia), are described in EP 37934 and 251194.
Patent FI-932957-A0 (FI)
Inventor: KILIUS DARREL E
IPC: C08L51/06
Filed: 1993-06-24
Abstract: Disclosed are compositions comprising, (a) a propylene polymer material grafted in the solid state with (i) styrenic polymer and further comprising (ii) ungrafted styrenic polymer, and, optionally (iii) a vinyl comonomer and when the optional vinyl comonomer is used, (iv) styrenic-vinyl copolymer; and (b) glass fibers treated with an organic silane compound; and optionally (c) at least one rubber polymer component comprising (1) from about 0 to 100% of at least one of (i) monoalkenyl aromatic hydrocarbon-conjugated diene block copolymers, (ii) hydrogenated products of (i), or (iii) mixtures of (i) and (ii); and (2) from about 100 to 0% of an olefin copolymer rubber; and (d) a coupling agent for the glass fibers and propylene polymer material plus said rubber polymer. The compositions exhibit a preferred balance of stiffness and impact strength at moderate cost and exhibit excellent surface qualities, making them particularly useful in molded parts.
Patent FI-933497-A0 (FI)
Inventor: RUPPEL REMY
IPC: B31F1/07
Filed: 1993-08-06
Abstract: Process for the manufacture of embossed laminated film consisting in: separately embossing a first and second film by the use of a first and second embossing device, each comprising a rubber cylinder (1, 4) and an engraved cylinder (2, 11) fitted wich a series of projections of a height of between 0.3 and 2 mm and of a density of between 3 and 20 projections per cm?2, applying at least partially an adhesive (60) on the tops of the projections on one of the films and fitting together both films using a mating cylinder (5) disposed parallel to one of the engraved cylinders, so that the projections are interlocking. The invention is characterized in that the mating cylinder (5) is metallic ou made of another equally hard material and in that it is held in abutment at a predefined minimum distance (H) from said engraved cylinder (2).
Patent FI-940729-A0 (FI)
Inventor: CLAESSON KNUT
IPC: B01D53/26
Filed: 1994-02-16
Abstract: PCT No. PCT/SE92/00585 Sec. 371 Date Jan. 12, 1994 Sec. 102(e) Date Jan. 12, 1994 PCT Filed Aug. 25, 1992 PCT Pub. No. WO93/04764 PCT Pub. Date Mar. 18, 1993.A method and apparatus for increasing the yield of an air-drying process with the aid of a dehumidifier 2 and a condenser/heat-exchanger 3 involves delivering wet regenerating air exiting the dehumidifier to one side of the condenser/heat-exchanger so as to deliver energy to the process air entering the other side. Condensation deriving from the regenerating air is collected and carried away, and the heated, dried process air 21 is delivered to the dehumidifier in which moisture is extracted from the air and the air further dried. The departing wet regenerating air may, after its delivery process, be led to the room, atmosphere or the flow of process air.
Patent FI-962268-A0 (FI)
Inventor: HOLLIS GREGORY FRANKLIN
IPC: C12N5/10
Filed: 1996-05-30
Abstract: A specific locus in the genome of a murine host cell is identified which causes high levels of recombinant gene expression following stable integration, via homologous recombination, of the recombinant gene into the specific chromosomal locus. The selection of a favorable genome locus for the insertion and expression of a recombinant gene is disclosed, as are DNA vectors and host cells.
Patent FI-964000-A0 (FI)
Inventor: XIE JIAN
IPC: G01R31/02
Filed: 1996-10-04
Abstract: The invention concerns a device for checking the insulation condition of alternating-current-carrying lines or cables, in particular overhead contact lines for railways, using an interposed electrical test resistance connected in series with the overhead line to limit the current and a voltage transformer connected to the other side of the test resistance to measure the voltage drop. In order to avoid the heating problems and high costs associated with the test resistances used in prior art devices, the invention proposes that an inductance (L1) be used as the current-limiting test resistance and that a compensation choke (L2) be connected, behind the inductance, between the overhead line and earth. In a preferred embodiment, the compensation inductance (L2) is designed to compensate or overcompensate for the line capacitance (C) in accordance with the relationship L2C  </=  1.
Patent FI-964600-A0 (FI)
Inventor: KONFINO ELIEZER
IPC: A01N37/18
Filed: 1996-11-15
Abstract: The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.
Patent FI-980340-A0 (FI)
Inventor: FORSSELL MIKA
IPC: H04W92/24
Filed: 1998-02-13
Abstract: A method of transmitting data in a packet radio network to a mobile station performing a routing area update. The packet radio network transmits data to the mobile station via a first support node. The mobile station sends a routing area update message to a second support node, which sends to the first support node a request for context data of the mobile station from the first support node. The first support node sends from its memory, end user data addressed to the mobile station to the second support node. It then waits for a predetermined period of time before sending the end user data to the second support node. The predetermined time may be fixed, depending preferably on the quality of service of the connection used by the mobile station. Alternatively the predetermined period of time expires when the second support note sends to the first support node a separate acknowledgement message indicating that the second support node has received the context data of the mobile station.
Patent IL-58319-A0 (IL)
Title: N-(1,2-azolyl)alkyl-halogenoacet anilides,their preparation and their use as herbicides
IPC: C07D231/18
Filed: 1979-09-25
Abstract: 1. N-(1,2-Azolyl)-alkyl-chloracetanilides of the formula  see diagramm : EP0010166,P23,F3  in which A represents oxygen, sulphur or the grouping > NR, R representing hydrogen or alkyl with 1 to 4 carbon atoms, R**1 represents alkyl with 1 to 4 carbon atoms, R**2 represents hydrogen or alkyl with 1 to 4 carbon atoms, R**3 represents hydrogen or alkyl with 1 to 4 carbon atoms, X**1 represents hydrogen or alkyl with 1 to 4 carbon atoms, X**2 represents hydrogen or alkyl with 1 to 4 carbon atoms and the azolyl radical is bonded via a carbon atom.
Patent IL-64436-A0 (IL)
Title: Antimycotic preparations in the form of elastic liquid plasters
IPC: A61K31/415
Filed: 1981-12-02
Abstract: 1. Claims for the contracting states : BE, CH, LI, DE, FR, GB, IT, NL, SE Antimycotic agents which have relatively good release of active compounds and contain azole derivatives and customary formulation auxiliaries, characterised in that they contain 2-10% by weight of a spreading agent from the group consisting of isopropyl myristate, isopropyl palmitate, isopropyl stearate, caprylates/caproates of saturated fatty alcohols having the chain length of C12 to C18 , wax-like fatty acid esters, such as synthesized duck uropygial gland fat, silicone oils, isopropyl myristate/isorpopyl palmitate/isopropyl stearate mixture, coconut fatty acid isopropyl ester, 1-8% by weight of a solubilising agent and, as a film-forming agent, a quick-drying polyvinylpyrrolidone, a terpolymer of 30% by weight of vinylpyrrolidone, 40% by weight of vinyl acetate and 30% by weight of vinyl propionate, or a vinylpyrrolidone/vinyl acetate copolymer. 1. Claims for the contracting state : AT Process for the production of antimycotics based on azole derivative active compounds and costumary formulation auxiliaries, characterised in that the active compounds and the formulation auxiliaries are formulated together with 2 to 10% by weight of isopropyl myristate, isopropylpalmitate, isopropyl stearate, caprylates/caproates of saturated fatty alcohols having the chain length of C12 to C18 , waxy fatty acid esters, such as synthesized duck uropygial gland fat, silicone oils, isopropyl myristate/isopropyl palmitate/isopropyl stearate mixture or cocount fatty acid isopropylester as spreading agents, 1 to 8% by weight of solubilising agents, based in each case on the total weight, and a quick drying polyvinylpyrrolidone, a terpolymer of vinylpyrrolidone/vinyl acetate/vinyl propionate in a ratio by weight of 30:40:30, or a vinylpyrrolidone/vinylacetate copolymer as the film-forming agent.
Patent IL-72556-A0 (IL)
Title: Pharmaceutical compositions for the treatment of perimenopausal,menopausal and post-menopausal disorders and multipreparation pack therefor
IPC: A61K31/565
Filed: 1984-07-31
Abstract: Prod. comprises one or more unit dosages of less than 2.5mg estrogen (I) and less than 30mg progestogen (II) with a carrier, pref. in a multi-prepn. pack. Also claimed is a prod. in the form of a parenteral slow release compsn., pref. an implant or intramuscular depot, which releases (I) and (II) in dosages equiv. to orally admin. daily dosages of 0.005-2.5mg, and 0.025-30mg resp.
Patent IL-73320-A0 (IL)
Title: Purine derivatives and pharmaceutical compositions containing them
IPC: C07C43/174
Filed: 1984-10-25
Abstract: Novel purine derivatives of formula <CHEM> as agents for treating autoimmune diseases are described. Also disclosed are processes for their production and pharmaceutical compositions comprising the compounds, as well as novel intermediates in the manufacture thereof.
Patent IL-78374-A0 (IL)
Title: Improvements in or relating to a process for purifying growth hormone-like materials
IPC: C07K1/20
Filed: 1986-03-31
Abstract: A process is provided for separating impurities from an impure mixture containing growth hormone-like material, which comprises:
 (1) applying said mixture to a reverse phase macroporous acryulate ester copolymer resin support at a pH of from about 7 to about 9; and
 (2) eluting said growth hormone-like material from said support with an aqueous eluant having a pH of from about 7 to about 9 and containing from about 20% to about 80% by volume of an organic diluent selected from the group consisting of acetone, acetonitrile, and a combination of acetone and acetonitrile.
Patent IL-84162-A0 (IL)
Title: Method and apparatus for mixing a sample and a diluent
IPC: G01N1/00
Filed: 1987-10-13
Abstract: In a chemical analysis apparatus a controlled sample liquid is passed through a non-wetting porous membrane (23) in a diluter assembly (12) from a reservoir of sample liquid to a flowing stream of diluent which is constantly flowing. The sample liquid penetrates the membrane (23) under a positive pressure differential from the sample side of the membrane (23). Control is provided by varying the resistance to flow of the sample liquid, and the pressure on the sample liquid, as it flows through the diluter assembly (12). Passage of the sample liquid through the membrane (23) requires a minimum liquid entry pressure differential across the membrane (23) to cause enough penetration to give a detectable presence of the sample liquid in the diluent stream for analysis by an analytical detector (19).
Patent IL-85257-A0 (IL)
Title: Pharmaceutical compositions containing a certain benzothiazepine derivative having renal function-improving effect and diuretic effect
IPC: A61K31/55
Filed: 1988-01-29
Abstract: Disclosed are an agent having a renal function-improving effect and a diuretic effect comprising as an active ingredient 2-(4-methoxyphenyl)-3-acetoxy-5-[2-(dimethylamino)ethyl]-8-chloro-2,3- dihydro-1, 5-benzothiazepin-4(5H)-one or a pharmaceutically acceptable acid addition salt thereof, and use of the same for preparing an agent having a renal function-improving effect and a diuretic effect.
Patent IL-92743-A0 (IL)
Title: Macrolide compounds
IPC: C12R1/01
Filed: 1989-12-17
Abstract: Fermentation product A83543 (1), comprising major components A83543A and A83543D and minor components A83543B, A83543C, A83543E, A983543F, A83543G, A83543H and A83543J, is produced by a newly described species, Saccharopolyspora spinosa. The A83543 components and their acid-addition salts (A83543 compounds) are useful as insecticides, particularly against Lepidoptera and Diptera species. Insecticidal, miticidal or ectoparasiticidal combinations, compositions and methods are provided. <CHEM>  wherein R is H or a group selected from <CHEM>  R<2> is <CHEM>  R<1>, R<3>, R<5> and R<6> are hydrogen or methyl; R4 is methyl or ethyl; or an acid addition salt thereof the compounds when R is other than hydrogen.
Patent AU-PM322393-A0 (AU)
Title: Mucin carbohydrate compounds and their use in immunotherapy
IPC: A61K39/385
Filed: 1993-12-24
Abstract: Conjugates between one or more repeated subunits of an antigen and a carbohydrate polymer are desired. Also described are immunogenic vaccines against disease states which contain the conjugates and methods for inducing cell-mediated immune responses. The conjugates may especially contain polymers of the carbohydrate mannose and one or more repeated subunits of human mucin.
Patent IL-100319-A0 (IL)
Title: Composition and method for protecting hair against thermal degradation and to aid in hair styling
IPC: A61K8/34
Filed: 1991-12-11
Abstract: A composition that protects the hair from thermal damage and doubles as an excellent hair styling aid, in the form of a hair spray, mousse foam or gel composition, and method of applying the composition to hair prior to substantial configuring of the hair in its final configuration. After application of the composition to wet or dry hair, prior to styling, the applied composition, including a polymer having a Tg less than about 120 DEG C, is heated to the glass transition temperature of the polymer, while the hair is in the desired configuration, and thereafter the heat is removed from the polymer to cool it to a temperature below its glass transition temperature to harden the polymer in a shape complimentary to that of the desired final hair configuration. The thermoplastic polymer fixative may include a plurality of sulfonated dicarboxylic acid moieties and/or neutralized sulfonate moietie. The composition includes a water and/or alcohol carrier, and a water-soluble or alcohol-soluble thermoplastic fixative polymer or resin in an amount of at least about 0.1% up to about 20% by weight of the composition, but below a level at which adjacent hair shafts are adhered together, and preferably, in an amount in the range of about 0.5% to about 4% of the composition, particularly about 0.5% to about 3% by weight of the composition. <IMAGE>
Patent IL-100495-A0 (IL)
Title: Production of phosphoric acid and hydrogen fluoride from phosphate rock and fluosilicic acid
IPC: C01B25/223
Filed: 1991-12-25
Abstract: A process for the preparation of phosphoric acid from a feedstock of phosphate rock and fluosilicic acid is described, which process comprises reacting the phosphate rock and the fluosilicic acid together to produce a reaction slurry of phosphoric acid, calcium fluoride, silicon dioxide and undigested phosphate rock and wherein an excess stoichiometric amount of calcium to fluorine is initially present in the slurry. The phosphoric acid and calcium fluoride is then separated and the phosphoric acid is finally recovered.
Patent IL-104362-A0 (IL)
Title: Flavour-masked pharmaceutical compositions and their preparation
IPC: A61K47/30
Filed: 1993-01-12
Abstract: The invention relates to taste-masked pharmaceutical compositions for oral use, to the production thereof and to the use thereof as medicines. The medicinal compositions according to the invention make it possible to administer pharmaceutical agents with very unpleasant organoleptic properties, such as very nasty taste, even in liquid form.
Patent IL-113044-A0 (IL)
Title: N-substituted beta-aryl- and beta-heteroaryl -alpha cyanoarylamide derivatives, their preparation and pharmaceutical compositions containing them
IPC: C07D217/12
Filed: 1995-03-20
Abstract: PCT No. PCT/EP95/00758 Sec. 371 Date Nov. 21, 1995 Sec. 102(e) Date Nov. 21, 1995 PCT Filed Mar. 2, 1995 PCT Pub. No. WO95/26341 PCT Pub. Date Oct. 5, 1995The present invention relates to new compounds of formula    <IMAGE>  (I)  wherein A is a bicyclic ring chosen from naphthalene, tetrahydronaphthalene, quinoline, isoquinoline and indole. B is a R2 substituted benzene ring or an unsubstituted pyridine or thiophene ring; R is hydrogen, C1-C6 alkyl, halogen, nitro, cyano, carboxy or a group NR3R4 wherein each of R3 and R4 is independently hydrogen or C1-C6 alkyl; R1 is hydrogen, C1-C6 alkyl or C1-C6 alkanoyl; R2 is hydrogen, C1-C6 alkyl, halogen, nitro, cyano, carboxy, hydroxy, C1-C6 alkoxy, C1-C6 alkanoyloxy or a group NR3R4 wherein R3 and R4 are as defined above; n is zero or an integer of 1 to 2; x is zero or an integer of 1 to 5; and the pharmaceutically acceptable salts thereof. The compounds of the invention are useful as tyrosine kinase inhibitors.
Patent IL-119700-A0 (IL)
Title: N-5-protected 2,5-diamino-4,6-dihydroxy-pyrimidines
IPC: C07D239/54
Filed: 1996-11-26
Abstract: N-5-protected 2,5-diamino-4,6-dichloropyrimidine derivs. of formula (I) are new: (where R = CF3 or alkoxy).
Patent IL-123487-A0 (IL)
Title: Loudspeakers comprising panel-form acoustic radiating elements
IPC: H04R1/00
Filed: 1996-09-02
Abstract: A panel-form loudspeaker (81) comprising a resonant distributed mode acoustic radiator having a periphery, a transducer (9) mounted to the radiator to excite distributed mode resonance in the radiator, and a frame (1) supporting the radiator, the transducer being coupled between the radiator and the frame to vibrate the panel to cause it to resonate to produce an acoustic output, characterised in that frame supports the radiator round its periphery and by resilient suspension means coupled between the frame and the radiator periphery.
Patent IL-140754-A0 (IL)
Title: Ink-receptive coatings and recording medium prepared therefrom
IPC: C08L29/04
Filed: 1999-07-08
Abstract: The coating composition comprises inorganic oxide, e.g., silica, in combination with a binder system comprising a mixture of a water soluble polymer and a non-ionic latex polymer. The composition may contain optional dye mordant (e.g., cationic polymer). It is found that the combinations of these components result in relatively high solids formulations (e.g., greater than 20 % by weight) with relatively low viscosity (less than 5000 centipoise), do not exhibit coating dusting, and give exceptional ink-jet printability. These formulations are especially suitable for preparing on-line formulations because they can be formulated to have a viscosity less than 2000 centipoise. Preferable embodiments for on-line coatings have a viscosity less than 1000 centipoise.
Patent IL-145487-A0 (IL)
Title: Apomorphine and sildenafil composition
IPC: A61K31/568
Filed: 2000-03-14
Abstract: The treatment of sexual dysfunction in human patients by an oral therapy regimen of administration of apomorphine and sildenafil is disclosed. This treatment optimizes the efficacy of each drug and substantially minimizes the undesirable side effects associated individually therewith. Apomorphine and sildenafil can be co-administered with a combination dosage unit or administered sequentially in separate dosage units, substantially prior to sexual activity. Other erectogenic agents can be administered along with apomorphine and sildenafil.
Patent IL-148920-A0 (IL)
Title: 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
IPC: A61P25/16
Filed: 2000-09-29
Abstract: The invention discloses the use of sapogenin derivatives in the treatment of cognitive dysfunction and similar conditions. Methods of treatment and pharmaceutical compositions are also disclosed.
Patent IL-149748-A0 (IL)
Title: Method for production of 1,3-disubstituted 2-nitroguanidines
IPC: C07D307/14
Filed: 2000-12-08
Abstract: The present invention relates to a process for the preparation of compounds of the formula (I)by reacting compounds of the formula (II)in whichHet, R1, R2 and R4 are as defined in the description,with anhydrous hydrogen chloride or compounds which generate hydrogen chloride.
Patent IL-150140-A0 (IL)
Title: Electronic label
IPC: G09F3/00
Filed: 2000-12-22
Abstract: Electronic labels consist of an electronic chip ( 4 ) and an antenna ( 3 ) assembled on a flexible support ( 2 ). The electronic chip ( 4 ) needs a rigid zone in order to not be damaged. This is why it is generally covered with a resin that makes this rigid region bigger. In order to reduce this zone the resin that covers the chip is suppressed and replaced with a protection ( 5 ) ensured by a rigid element added to the flexible support ( 2 ).
Patent IL-151562-A0 (IL)
Title: Method and apparatus for manufacturing structures with improved fatigue life
IPC: C21D7/02
Filed: 2001-02-09
Abstract: A method for cold working metal structures. A compound indenter is used to produce deformation in a workpiece, to provide a selected beneficial residual stress profile, to provide improved fatigue life structures with minimal manufacturing steps. A compound indenter deforms a workpiece, resulting in dimples therein. A relatively uniform beneficial residual stress profile is provided at the surface and at the midplane of apertures in a workpiece, so as to improve overall fatigue life. A compound indenter tool having a first, elongate indenter with a shaped indenter surface portion, and a second shaped indenter surrounding the first indenter and forming an annular shoulder recessed from the surface portion of the first indenter, is used. Optionally, a foot having a bottom portion is used to confiningly surround an indenter during application of deforming force to the surface of a workpiece, to prevent deformation of adjacent workpiece surface.
Patent IL-166446-A0 (IL)
Title: Platinum complexes containing chemically modified bile acids having antitumor activity
IPC: C07J51/00
Filed: 2005-01-23
Abstract: The present invention relates to platinum complexes containing bile acid derivatives having antitumor activity